Genetic Analysis of Pheochromocytomas, Paragangliomas and Associated Conditions

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorThe University of Texas Health Science Center at San Antonio

About this trial

Pheochromocytomas and paragangliomas are neural crest-derived tumors of the nervous system that are often inherited and genetically heterogeneous. Genetic screening is recommended for patients and their relatives, and can guide clinical decisions. However, a mutation is not found in all cases. The aims of this proposal are to: 1) to map gene(s) involved in pheochromocytoma, and 2) identify genotype-phenotype correlations in patients with pheochromocytoma/paraganglioma of various genetic origins.

Eligibility criteria

Qualifiers

diagnosis of pheochromocytoma and or paraganglioma

family member with diagnosis of pheochromocytoma and or paraganglioma

diagnosis of a pheochromocytoma- and or paraganglioma-associated condition

family member with diagnosis of a pheochromocytoma- and or paraganglioma-associated condition

Disqualifiers

unconfirmed diagnosis of pheochromocytoma and/or paraganglioma or associated condition

Trial design

Treatments tested in this trial

  • Genetic screening

Treatment groups

No treatment groups listed

Sponsors and collaborators

The University of Texas Health Science Center at San Antonio

Lead sponsor

National Institute of General Medical Sciences (NIGMS)

Collaborator

The Paradifference Foundation

Collaborator

National Cancer Institute (NCI)

Collaborator